Company profile
Vor Biopharma Inc. insider acquisitions
Company CIK 0001817229 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Exercise / conversionCode M | Common StockNon-derivative · Currency not specified | 1 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
7 dated transactions · 8 of 9 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 2, 2026 | Vor Biopharma Inc.Common Stock | RA Capital Healthcare Fund LP · RA CAPITAL MANAGEMENT, L.P. · Kolchinsky Peter · Shah Rajeev M. | Exercise / conversion |
| Dec 18, 2025 | Vor Biopharma Inc.Stock Option (Right to Buy) | Joustra Wouter | Stock award |
| Dec 18, 2025 | Vor Biopharma Inc.Stock Option (Right to Buy) | Levin Andrew David | Stock award |
| Dec 18, 2025 | Vor Biopharma Inc.Stock Option (Right to Buy) | RA Capital Healthcare Fund LP · RA CAPITAL MANAGEMENT, L.P. · Kolchinsky Peter · Shah Rajeev M. | Stock award |
| Dec 5, 2025 | Vor Biopharma Inc.Employee Stock Option (right to buy) | Zuraw Qing Che | Stock award |
| Dec 5, 2025 | Vor Biopharma Inc.Employee Stock Option (right to buy) | Kress Jean-Paul | Stock award |
| Dec 5, 2025 | Vor Biopharma Inc.Employee Stock Option (right to buy) | Mahatme Sandesh | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
VOR · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | RA Capital Healthcare Fund LP10% owner RA CAPITAL MANAGEMENT, L.P.10% owner Kolchinsky Peter10% owner Shah Rajeev M.10% owner Joint filing · amounts unallocated | Exercise / conversionCommon StockNon-derivative security · Code M | 500 | 12.8Value: 6,400Currency not specified | View ↗ |
| Trade: | Joustra WouterDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 3,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Levin Andrew DavidDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 3,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | RA Capital Healthcare Fund LPDirector · 10% owner RA CAPITAL MANAGEMENT, L.P.Director · 10% owner Kolchinsky PeterDirector · 10% owner Shah Rajeev M.Director · 10% owner Joint filing · amounts unallocated | Stock awardStock Option (Right to Buy)Derivative security · Code A | 3,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Zuraw Qing CheChief Development Officer | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 218,652 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Kress Jean-PaulCEO and Chairman · Director | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 4,164,831 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Stock awardEmployee Stock Option (right to buy)Derivative security · Code A | 1,388,274 | 0Value: 0Currency not specified | View ↗ |
7 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →